hydrochlorothiazide and semaglutide (HCTZ) Tablets Moduretic (Amiloride Hydrochloride / Hydrochlorothiazide)

doi: 10.1016/j.drudis.2021.04.025 188 XieYZhengJLiSLiHZhouYZhengWet al

This personalization is typically unavailable through insurance-covered care, making it a unique advantage of direct-access GLP-1 therapy

Byetta (exenatide twice daily) was one of the earliest GLP-1 receptor agonists available in the United States, while Bydureon offered a once-weekly version of the same active ingredient

The benefit of Se supplementation could be expected in patients living in regions with low Se availability or who have low- or sub-optimal Se levels

Relative risk of acute pancreatitis in initiators of exenatide twice daily compared with other anti-diabetic medication: a follow-up study

Given the increasing real-world use of combined therapy and the limited HF-specific evidence base, this review summarizes current data regarding the comparative and combined effects of GLP-1 receptor agonists and SGLT2 inhibitors in HF, with emphasis on efficacy, safety, mechanistic rationale, and evidence gaps